| P50 | author | Hala Gali-Muhtasib | Q51113283 |
| | Mona Diab-Assaf | Q83389326 |
| P2093 | author name string | Makhluf J Haddadin | |
| P2860 | cites work | Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 |
| | Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors | Q28297412 |
| | Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo | Q28368373 |
| | Transforming growth factor beta 1 induces apoptosis through cleavage of BAD in a Smad3-dependent mechanism in FaO hepatoma cells | Q28573394 |
| | Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis | Q29547567 |
| | Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis | Q31835293 |
| | Development of anticancer drugs targeting the MAP kinase pathway | Q34293560 |
| | TGF-beta antagonists: why suppress a tumor suppressor? | Q34691800 |
| | Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression. | Q35594463 |
| | Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells | Q40735877 |
| | Quinoxaline 1,4-dioxides: hypoxia-selective therapeutic agents | Q40740278 |
| | Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs. | Q40813759 |
| | Oncogenic Ki-ras confers a more aggressive colon cancer phenotype through modification of transforming growth factor-beta receptor III. | Q40849516 |
| | Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation | Q40958044 |
| | Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells | Q41039392 |
| | Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases | Q41079552 |
| | Differential contribution of the ERK and JNK mitogen-activated protein kinase cascades to Ras transformation of HT1080 fibrosarcoma and DLD-1 colon carcinoma cells | Q41615168 |
| | Evidence that inhibition of p44/42 mitogen-activated protein kinase signaling is a factor in proteasome inhibitor-mediated apoptosis | Q44002712 |
| | Perturbation by geraniol of cell membrane permeability and signal transduction pathways in human colon cancer cells. | Q44186080 |
| | Bcl-2 family proteins | Q46508339 |
| | TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. | Q51714404 |
| | Antibacterial properties of quindoxin: a new growth-promoting agent | Q69167710 |
| | Expression of TGF-alpha/EGF and TGF-beta receptors in human colon carcinoma cell lines | Q69352119 |
| | Apoptosis induction by the satratoxins and other trichothecene mycotoxins: relationship to ERK, p38 MAPK, and SAPK/JNK activation | Q73675558 |
| | In vivo activation of mitogen-activated protein kinases in rat intestinal neoplasia | Q73835503 |
| | Aberrant transforming growth factor-beta signaling in azoxymethane-induced mouse colon tumors | Q74460983 |
| | MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis | Q77840753 |
| P5824 | is retracted by | Retraction Note to: Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells | Q47178038 |
| P433 | issue | 4 | |
| P921 | main subject | colon cancer | Q18555025 |
| P304 | page(s) | 369-378 | |
| P577 | publication date | 2004-11-05 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Quinoxaline 1,4-dioxides induce G2/M cell cycle arrest and apoptosis in human colon cancer cells | |
| P478 | volume | 55 | |